AustralianSuper Pty Ltd Sells 492,309 Shares of CVS Health Corporation $CVS

AustralianSuper Pty Ltd lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 71.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 200,676 shares of the pharmacy operator’s stock after selling 492,309 shares during the quarter. AustralianSuper Pty Ltd’s holdings in CVS Health were worth $15,129,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of CVS. Norges Bank bought a new position in shares of CVS Health during the 2nd quarter worth $1,358,698,000. Invesco Ltd. raised its holdings in shares of CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after buying an additional 3,118,626 shares during the last quarter. Vanguard Group Inc. grew its stake in CVS Health by 1.7% during the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after purchasing an additional 2,063,737 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in CVS Health by 153.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,105,827 shares of the pharmacy operator’s stock worth $214,240,000 after buying an additional 1,878,217 shares during the period. Finally, Panagora Asset Management Inc. raised its holdings in shares of CVS Health by 2,675.7% during the second quarter. Panagora Asset Management Inc. now owns 1,116,742 shares of the pharmacy operator’s stock worth $77,033,000 after purchasing an additional 1,076,509 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 1.5%

CVS stock opened at $80.41 on Wednesday. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The company has a market cap of $102.30 billion, a P/E ratio of 58.27, a P/E/G ratio of 0.85 and a beta of 0.49. The company’s 50-day moving average price is $78.50 and its 200 day moving average price is $77.47.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company’s revenue was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. JPMorgan Chase & Co. raised their price target on shares of CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Wells Fargo & Company cut their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research note on Thursday, November 13th. Wolfe Research dropped their price objective on CVS Health from $100.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday. Bank of America decreased their price objective on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Finally, Robert W. Baird lifted their price target on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Nineteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $94.77.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.